Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
02/13/2024 | ACADIAN ASSET MANAGEMENT LLC | 199,600 | $6,000 | -47.91% | 1.63% |
01/16/2024 | RAYMOND JAMES & ASSOCIATES | 10,000 | $370 | 0.00% | 0.08% |
02/09/2024 | US BANCORP \DE\ | 0 | $0 | -100.00% | 0.00% |
02/09/2024 | WELLS FARGO & COMPANY/MN | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | NORTHERN TRUST CORP | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | STATE STREET CORP | 0 | $0 | -100.00% | 0.00% |
03/11/2024 | VANGUARD GROUP INC | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | MORGAN STANLEY | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | GROUP ONE TRADING, L.P. | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | TWO SIGMA INVESTMENTS, LP | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | BLACKROCK INC. | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | CITADEL ADVISORS LLC | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | TWO SIGMA ADVISERS, LP | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 0 | $0 | -100.00% | 0.00% |
02/12/2024 | ADVISOR GROUP HOLDINGS, INC. | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 0 | $0 | -100.00% | 0.00% |
01/12/2024 | GPS WEALTH STRATEGIES GROUP, LLC | 0 | $0 | -100.00% | 0.00% |
01/02/2024 | GLOBAL WEALTH STRATEGIES & ASSOCIATES | 0 | $0 | -100.00% | 0.00% |
01/29/2024 | PFS PARTNERS, LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 10 institutional investors and hedge funds held shares of Bellerophon Therapeutics, Inc.. The most heavily invested institutionals were:
ACADIAN ASSET MANAGEMENT LLC: 0
RAYMOND JAMES & ASSOCIATES: 0
CITADEL ADVISORS LLC: 0
BlackRock Inc.: 0
NORTHERN TRUST CORP: 0
Tower Research Capital LLC (TRC): 0
A. 1.71% of Bellerophon Therapeutics, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 1.20 M shares in the last 24 months. This purchase volume represents approximately $59,892 in transactions.